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1. Introduction 
The mechanism of DNA replication in viva is not 
yet clarified [l] . In view of complex organization of 
DNA in nuclei of eukaryotic organisms, the replication 
mechanism is mostly being studied in simpler systems, 
in bacteria and in the organelles of eukaryotic cells, 
i.e. chloroplasts and mitochondria. 
In yeast, disturbance in replication of mitochrondrial 
DNA (mt-DNA) results in the formation of cytoplasmic 
respiration-deficient mutants [2, 31 . The mutants have 
proven to be invaluable tools in the study of cyto- 
plasmic heredity and of the structure and function of 
mitochondria. More recently, the potentialities for the 
elucidation of the mechanism of DNA replication have 
been implicated [4-71. 
This paper shows that nalidixic acid, an inhibitor of 
DNA replication in bacteria [8,9], prevents the 
induction of the respiration-deficient @-) mutants 
by ethidium or acriflavin. External circumstances have 
caused a delay in the publication of these results. In 
the meantime, Hollenberg and Borst [lo] reported 
that nalidixic acid at a concentration of 500 /~/ml 
inhibited the induction of p- mutants by ethidium and 
concluded that mt-DNA replication may be required 
for mutant induction. In this paper, a different inter- 
pretation, assuming interference of nalidixic acid in 
nicking-closing cycles of mt-DNA triggered by 
ethidium, is proposed and additional data are 
presented to support the interpretation. 
* Present address: Department of Organic Chemistry and Bio- 
chemistry, Komensky University, Bratislava, Czechoslovakia. 
2. Experimental 
Diploid wild-type yeast Saccharomyces cerevisiae 
DT XII was grown in a synthetic medium (Yeast 
nitrogen base, Difco) with 2% glucose as carbon source 
and buffered to pH 5 .O with 50 mM phthalate buffer. 
Erlenmeyer flasks were filled to l/l 0 of their volume 
with the medium, inoculated to lo6 cells/ml and in- 
cubated on a shaker at 30”. The cells were plated, 
after suitable dilution with water, onto a semi- 
synthetic medium with 0.1% glucose and 2% glycerol. 
Respiration-deficient colonies were detected by their 
small size and by the tetrazolium overlay method [ 111 . 
Cells were counted in a haemocyte chamber. 
Difference spectra (reduced by endogenous sub- 
strate and dithionite minus oxidized by 60 mM 
H,O,) were recorded in the Hitachi-Perkin Elmer 
356 spectrophotometer. Respiration was measured by 
the conventional manometric technique. Interaction 
of ethidium bromide with nucleic acid was followed 
spectrophotometrically [ 121 or spectrofluoro- 
metrically [ 131 . 
Ethidium bromide was a product of Serva, nalidixic 
acid of Calbiochem, erythromycin lactobionate of 
Abbot and highly polymerized DNA of Sigma. LyLe 
RNA was a gift from Dr. C. Altaner. 
3. Results 
As can be seen in fig. 1, ethidium bromide induced 
100% of respiration-deficient mutants when the cells 
were grown in the synthetic medium with glucose as 
carbon source. The formation of mutants was not 
inhibited by erythromycin (2 mg/ml) or cycloheximide 
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Fig. 1. Growth curves and induction of respiration-deficient (p-) mutants in the presence of ethidium bromide (10 PM), cyclo- 
heximide (25 &ml), erythromycin (2 mg/ml) and nalidixic acid (430 MM). 1) Without inhibitor; 2) ethidium; 3) erythromycin; 
4) ethidium + erythromycin; 5) cycloheximide; 6) ethidium + cycloheximide; 7) nalidixic acid; 8) ethidium + nalidixic acid. 
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Fig. 2. Reversion of the formation of respiration-deficient 
Go3 mutants. The cells were cultured in the presence of 10 
PM ethidium bromide and, at time indicated by arrows, 
nalidixic acid (final cont. 430 PM) was added. (-): 
Growth in the presence of ethidium; (+ ): growth in 
the presence of ethidium and nalidixic acid. 
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Fig. 3. Difference spectra and respiratory activity of yeast 
grown aerobically for 24 hr in the absence of inhibitor (a), in 
the presence of 10 PM ethidium bromide (b), of 430 PM 
nalidixic acid (c), and 10 PM ethidium bromide + 430 PM 
nalidixic acid (d). Numbers on curves indicate respiratory 
activity (~1 Oa/mg dry weight cells/hr) with 50 mM glucose 
as substrate. 
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Fig. 4. Absorption spectra of ethidium bromide in the presence of nalidixic acid and nucleic acids. 1) 5 MM ethidium; 2) 20 PM 
nalidixic acid; 3) 5 pM nalidixic acid; circles on curve 1 correspond to spectrum 3 minus 2; 4) 100 pM ethidium; 5) 100 nM 
ethidium + 620 pM RNA; the same spectrum was recorded if 330 pM nahdixic acid was also added (before or after ethidium); 
6) 100 PM ethidium + 850 nM DNA; 330 pM nalidixic acid did not affect the spectrum. 
(25 pg/ml), the respective inhibitors of mitochondrial 
and cytoplasmic protein synthesis. The induction of 
mutants was completely prevented by nalidixic acid 
(2 15 PM; 50 &ml). Growth rate was slightly lower 
in the presence of nalidixic acid but the final growth 
yield was almost as high as in the control culture in 
the absence of the drug. 
The prevention of the mutant induction was 
studied as a function of nalidixic acid concentration. 
In the presence of 0,43, 129 and 215 PM nalidixic 
acid (and 10 PM ethidium bromide), 100, 53,9 and 
0% mutants were formed, respectively. 
Fig. 2 shows that the induction of mutants was 
partly reversed by nalidixic acid in the first few hours 
of growth in the presence of ethidium. Apparently, 
ethidium first brings the cells into a “premutational 
state” [7] from which they can either be converted 
into respiration-deficient mutants, even if ethidium is 
removed by dilution which precedes plating, or recover 
if nalidixic acid is added to prevent the conversion. 
Respiratory activity and spectra of yeast grown 
aerobically in the presence of the drugs are shown in 
fig. 3. Formation of cytochromes a and b as well as 
development of the respiratory activity were inhibited 
by ethidium. Nalidixic acid did not substantially 
affect the formation of the respiratory pigments and 
the development of the respiratory activity. It also 
eliminated the inhibitory effect of ethidium. As 
normal synthesis of mt-DNA seems to be required for 
the formation of the mitochondrial respiratory 
system [ 14, 151, nalidixic acid did not apparently 
interfere substantially with the synthesis of mt-DNA 
in the strain employed. 
A possible chemical interaction of nalidixic acid 
with ethidium and its interference with complex 
formation between ethidium and nucleic acid was 
examined. As shown in fig. 4, nalidixic acid did not 
affect the absorption spectrum of ethidium and 
vice versa, thus making a direct chemical interaction 
of the two drugs improbable. Intercalation of 
ethidium bromide into RNA and DNA, as determined 
by an absorption shift [ 121, was found not to be 
affected by nalidixic acid (fig. 4). This was confirmed 
by observing the intercalation by a fluorimetric pro- 
cedure [15]. 
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[ 171 demonstrated that a DNA of highly supercoiled 
structure could be isolated from human cells 
cultured in the presence of ethidium bromide. The 
longer the cells were in contact with the drug, the 
higher was the superhelix density of the DNA isolated 
from the cells. They have assumed that, in the 
presence of ethidium or other intercalating drugs, the 
complex of the drug with non-replicating mt-DNA in 
the cell undergoes repeated nicking and closing which 
yields a mt-DNA with a low topological winding 
number and, after isolation and purification when the 
regular duplex structure is assumed, a highly super- 
coiled molecule results. 
It may be hypothesized that a similar nicking- 
closing cycle takes place in yeast mitochondria when 
loaded with an intercalating drug. Actually, the drug 
may trigger such a cycle and in this way induce the 
labile “premutational state” [7] in the cell. In the 
course of the continuous nicking and closing, the 
unwinding of the mt-DNA duplex is progressing and, 
in “petite-positive” yeast [ 18, 191, may be followed 
by degradation of mt-DNA to molecules of abnormal 
buoyant densities [20-221 or by a total loss of 
mt-DNA [23,24]. 
Since nalidixic acid has been found not to interfere 
with intercalation of ethidium into nucleic acid in 
vitro, the nicking-closing cycle may be prerequisite for 
extensive intercalation of the drug in vivo and 
nalidixic acid would interfere either with the nicking 
or the closing reaction. This may be the reason why it 
prevents the effect of ethidium on the induction of 
p- mutants and also on the synthesis of the respiratory 
system. 
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The nicking and closing has been considered 
obligatory for replication of closed circular DNA 
[l, 25-281 . It may be more important for replication 
of large bacterial DNA than for a relatively short 
mt-DNA, the length ratios of the two being approx. 
200: 1. With the strain employed in this study, 
nalidixic acid only slightly inhibited synthesis of 
respiratory pigments and (unpublished observation) 
did not substantially interfere with respiratory 
adaptation of anaerobically-grown yeast or present 
growth on non-fermentable substrates (cf. [14, 29, 
301 . This implies that replication of mt-DNA in yeast 
could still take place almost undisturbed in the 
presence of nalidixic acid, while the replication of 
bacterial DNA is completely arrested [8,9]. The 
interpretation is compatible with the observations 
that the replication of phage DNA and some repair 
processes in nalidixic acid-sensitive cells have not 
been impaired by nalidixic acid [31,32] . 
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